<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Various therapeutic options are available for the management of <z:mpath ids='MPATH_653'>Langerhans cell histiocytosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>However, treatment administered to control this disease may be complicated by <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>CASE PRESENTATION: A 34 years old male was diagnosed to have <z:mpath ids='MPATH_653'>Langerhans cell histiocytosis</z:mpath> in March 1999 </plain></SENT>
<SENT sid="3" pm="."><plain>Unfortunately, the cytotoxic chemotherapy and radiotherapy given to control the repeated relapses and exacerbations of the <z:e sem="disease" ids="C0277554" disease_type="Disease or Syndrome" abbrv="">primary disease</z:e> predisposed him to therapy-induced <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> which transformed into <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>After achieving complete remission of his <z:hpo ids='HP_0001909'>leukemia</z:hpo>, the patient received an allogeneic hematopoietic stem cell transplant </plain></SENT>
<SENT sid="5" pm="."><plain>The allograft was complicated by <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft versus host disease</z:e> that was controlled by various <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> and extracorporal photophoresis </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Management of complicated cases of <z:mpath ids='MPATH_146,MPATH_652'>histiocytosis</z:mpath> requires various therapeutic modalities and a multidisciplinary approach </plain></SENT>
<SENT sid="7" pm="."><plain>Having complications of therapy eg <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> or <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> make the outcome more dismal and the management options limited to aggressive forms of treatment </plain></SENT>
<SENT sid="8" pm="."><plain>High dose chemotherapy followed by an allograft may be a curative option not only for therapy-related <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>/<z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, but also for frequently relapsing and poorly controlled <z:mpath ids='MPATH_653'>Langerhans cell histiocytosis</z:mpath> </plain></SENT>
</text></document>